SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Al Collard who wrote (1112)10/31/2000 9:03:29 AM
From: Grashopper  Respond to of 1321
 
WITH TODAY'S INDICATORS AND the skin cancer release we are going back to 56; perhaps today JMHO



To: Al Collard who wrote (1112)10/31/2000 9:56:26 AM
From: BostonView  Read Replies (1) | Respond to of 1321
 
Exremely bullish development! Between the liklihood of expanded labeling for Visudyne, and possible future approval for new indications like skin cancer, QLT is destined to become quite a little biotech powerhouse. Maybe not so little in a few years!

BV


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News